Showing results (261-270 of 301) with videos related to

Sort By:
Pageof 31
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 29, 2019
Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantationTakeo Toshima, Tomoharu Yoshizumi, Shoichi Inokuchi, et al.
Surgery Today|August 27, 2024
Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: a Japanese multicenter studyNorifumi Iseda, Shinji Itoh, Takeo Toshima, et al.
Surgical Case Reports|July 5, 2016
A long survivor with local relapse of hilar cholangiocarcinoma after R1 surgery treated with chemoradiotherapy: a case report and literature reviewHirohisa Okabe, Akira Chikamoto, Masataka Maruno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 3, 2026
PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived ModelKatsuya Toshida, Kazuki Takeishi, Shinji Itoh, et al.
Surgery Today|January 6, 2026
Impact of thyroid-stimulating hormone ratio change on the progression-free survival of patients receiving gemcitabine, cisplatin, and durvalumab therapy for advanced biliary tract cancerMichinori Matsumoto, Shinji Itoh, Masashi Tsunematsu, et al.
Oncology Letters|February 14, 2022
Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinomaTakahiro Tomiyama, Shinji Itoh, Norifumi Iseda, et al.
Plos One|April 22, 2016
Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and PrognosisHirohisa Okabe, Hiroki Kinoshita, Katsunori Imai, et al.
Medicine|April 12, 2018
Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case reportKotoe Takayoshi, Goro Doi, Nobuhiro Tsuruta, et al.
Liver Cancer|October 9, 2025
Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT StudyMasatoshi Kudo, Kazuomi Ueshima, Kaoru Tsuchiya, et al.
Annals of Surgical Oncology|January 14, 2023
Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular CarcinomaTakahiro Tomiyama, Shinji Itoh, Norifumi Iseda, et al.
Pageof 31